Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katharina, Sprute"'
Autor:
Stefan A. Koerber1,2,3 (AUTHOR) Stefan.Koerber@med.uni-heidelberg.de, Katharina Sprute4 (AUTHOR), Clemens Kratochwil4,5 (AUTHOR), Erik Winter4 (AUTHOR), Matthias F. Haefner1,2,3 (AUTHOR), Sonja Katayama1,2,3 (AUTHOR), Ingmar Schlampp1,2,3 (AUTHOR), Klaus Herfarth1,2,3,6 (AUTHOR), Klaus Kopka7,8,9 (AUTHOR), Ali Afshar-Oromieh10 (AUTHOR), Stefanie Zschaebitz11 (AUTHOR), Tim Holland-Letz12 (AUTHOR), Peter L. Choyke13 (AUTHOR), Dirk Jaeger11 (AUTHOR), Markus Hohenfellner14 (AUTHOR), Uwe Haberkorn4,5 (AUTHOR), Juergen Debus1,2,3,6,9,15 (AUTHOR), Frederik L. Giesel4,5,9 (AUTHOR)
Publikováno v:
European Journal of Nuclear Medicine & Molecular Imaging. 2021, Vol. 48 Issue 1, p143-151. 9p. 1 Color Photograph, 4 Charts, 3 Graphs.
Autor:
Clemens Kratochwil, Horacio Amaral, Camilo Sandoval, Frederik L. Giesel, Markus Hohenfellner, Katharina Sprute, M. Eiber, Norio Nonomura, Sadahiro Naka, Manuel Meneses, Jun Hatazawa, Viktoria Schütz, Tim Holland-Letz, Michael Schaefers, P. L. Choyke, Uwe Haberkorn, Juergen Debus, Cristian Soza-Ried, René Fernández, Vasko Kramer, Tadashi Watabe, Constantin Schwab, Kambiz Rahbar, Motohide Uemura, Isabel Rauscher, Stefan A. Koerber, Wolfgang Weber
Publikováno v:
Journal of Nuclear Medicine. 62:208-213
Prostate-specific membrane antigen (PSMA)-ligand PET/CT is performed on patients with prostate cancer to stage the disease initially or to identify sites of recurrence after definitive therapy. On the basis of clinical results, 18F-PSMA-1007 is a pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fa5b9e7bc98ca36a99c920746608219
https://doi.org/10.2967/jnumed.120.246363
https://doi.org/10.2967/jnumed.120.246363
Autor:
Katharina, Sprute, Vasko, Kramer, Stefan A, Koerber, Manuel, Meneses, Rene, Fernandez, Cristian, Soza-Ried, Mathias, Eiber, Wolfgang A, Weber, Isabel, Rauscher, Kambiz, Rahbar, Michael, Schaefers, Tadashi, Watabe, Motohide, Uemura, Sadahiro, Naka, Norio, Nonomura, Jun, Hatazawa, Constantin, Schwab, Viktoria, Schütz, Markus, Hohenfellner, Tim, Holland-Letz, Juergen, Debus, Clemens, Kratochwil, Horacio, Amaral, Pete L, Choyke, Uwe, Haberkorn, Camilo, Sandoval, Frederik L, Giesel
Publikováno v:
Journal of Nuclear Medicine
Prostate-specific membrane antigen (PSMA)–ligand PET/CT is performed on patients with prostate cancer to stage the disease initially or to identify sites of recurrence after definitive therapy. On the basis of clinical results, 18F-PSMA-1007 is a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6af89fc847a0ff8a1750b1de011a9c32
https://pubmed.ncbi.nlm.nih.gov/32817141
https://pubmed.ncbi.nlm.nih.gov/32817141
Autor:
Ingmar Schlampp, Tim Holland-Letz, Klaus Kopka, Frederik L. Giesel, Erik Winter, Stefan A. Koerber, Stefanie Zschaebitz, Clemens Kratochwil, Katharina Sprute, Ali Afshar-Oromieh, Juergen Debus, Markus Hohenfellner, Peter L. Choyke, Matthias F. Haefner, Dirk Jaeger, Uwe Haberkorn, Sonja Katayama, Klaus Herfarth
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging (2020)
European Journal of Nuclear Medicine and Molecular Imaging 48(2021), 143-151
European Journal of Nuclear Medicine and Molecular Imaging (2020)
European Journal of Nuclear Medicine and Molecular Imaging 48(2021), 143-151
Purpose First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1af7af4fea06fd55dfdaaeb1e4445ed
https://pubmed.ncbi.nlm.nih.gov/32405735
https://pubmed.ncbi.nlm.nih.gov/32405735